• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫体孤立性纤维瘤的风险评估:病例报告及文献系统回顾。

Risk Assessment in Solitary Fibrous Tumor of the Uterine Corpus: Report of a Case and Systematic Review of the Literature.

机构信息

18515Unit of Pathology, ASST Spedali Civili di Brescia, Brescia, Italy.

9242Pathology Unit, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy.

出版信息

Int J Surg Pathol. 2022 Apr;30(2):177-183. doi: 10.1177/10668969211025759. Epub 2021 Jun 28.

DOI:10.1177/10668969211025759
PMID:34180727
Abstract

Solitary fibrous tumor (SFT) is an uncommon fibroblastic tumor occurring preferentially in the pleura, with a variable clinical course. SFT can arise also in numerous extrathoracic sites and very rarely in the female genital tract, with only scarce reports of uterine SFT. We reported a new uterine SFT arising in a 45-year-old woman, and we performed a systematic review of SFT cases of the uterine corpus interrogating the electronic databases PubMed, Web of Science, and Scopus. We identified only 13 patients diagnosed with SFT of the uterine corpus, including our one. Complete clinical workout at disease presentation showed no evidence of extrauterine spread in all cases, except for 1 patient who presented with metastatic disease. Tumor recurrences/metastases occurred in a minority of the patients and were poorly related to clinicopathological risk factors and patients stratification based on different scoring systems. Since the long-term clinical behavior of uterine SFT is limited and poorly predictable, extended follow-up is recommended also for all cases arising in the uterine corpus.

摘要

孤立性纤维瘤(Solitary fibrous tumor,SFT)是一种罕见的成纤维细胞肿瘤,主要发生于胸膜,具有不同的临床病程。SFT 也可发生于许多胸腔外部位,非常罕见于女性生殖道,仅有少数子宫 SFT 的报道。我们报告了一例发生于 45 岁女性的新的子宫 SFT,并通过检索 PubMed、Web of Science 和 Scopus 电子数据库,对子宫体 SFT 病例进行了系统回顾。我们共确定了 13 例诊断为子宫体 SFT 的患者,包括我们的病例。所有患者在疾病表现时的全面临床检查均未显示有子宫外播散的证据,除了 1 例患者存在转移性疾病。少数患者出现肿瘤复发/转移,且与临床病理危险因素及基于不同评分系统的患者分层相关性较差。由于子宫 SFT 的长期临床行为有限且难以预测,因此建议对所有发生于子宫体的病例进行延长随访。

相似文献

1
Risk Assessment in Solitary Fibrous Tumor of the Uterine Corpus: Report of a Case and Systematic Review of the Literature.子宫体孤立性纤维瘤的风险评估:病例报告及文献系统回顾。
Int J Surg Pathol. 2022 Apr;30(2):177-183. doi: 10.1177/10668969211025759. Epub 2021 Jun 28.
2
Surveillance for metastatic hemangiopericytoma-solitary fibrous tumors-systematic literature review on incidence, predictors and diagnosis of extra-cranial disease.颅内血管外皮细胞瘤-孤立性纤维瘤的监测:系统文献复习颅外疾病的发生率、预测因素和诊断。
J Neurooncol. 2018 Jul;138(3):447-467. doi: 10.1007/s11060-018-2836-2. Epub 2018 Mar 17.
3
Metastatic Patterns of Solitary Fibrous Tumors: A Single-Institution Experience.孤立性纤维性肿瘤的转移模式:单中心经验
AJR Am J Roentgenol. 2017 Jan;208(1):2-9. doi: 10.2214/AJR.16.16662. Epub 2016 Oct 20.
4
Solitary Fibrous Tumor of the Uterus Presenting With Lung Metastases: A Case Report.以肺转移为表现的子宫孤立性纤维瘤:病例报告
Int J Gynecol Pathol. 2016 Jan;35(1):25-9. doi: 10.1097/PGP.0000000000000197.
5
Solitary fibrous tumour of the female genital tract: a clinicopathological analysis of 25 cases.女性生殖道孤立性纤维性肿瘤:25 例临床病理分析。
Histopathology. 2018 Apr;72(5):749-759. doi: 10.1111/his.13430. Epub 2018 Jan 26.
6
Intrapulmonary solitary fibrous tumors: clinicopathologic and immunohistochemical study of 24 cases.肺内孤立性纤维性肿瘤:24 例临床病理和免疫组化研究。
Am J Surg Pathol. 2013 Feb;37(2):155-66. doi: 10.1097/PAS.0b013e31826a92f5.
7
Solitary fibrous tumor of the parapharyngeal space: report of 2 cases and a literature review.咽旁间隙孤立性纤维瘤 2 例报告并文献复习
Oral Maxillofac Surg. 2024 Sep;28(3):1415-1421. doi: 10.1007/s10006-024-01241-2. Epub 2024 Apr 2.
8
Solitary fibrous tumor of the breast: A case report and the review of the literature.乳腺孤立性纤维瘤:一例病例报告及文献复习
Breast J. 2018 Jan;24(1):78-81. doi: 10.1111/tbj.12841. Epub 2017 Jun 16.
9
Malignant solitary fibrous tumor of breast: a rare case report.乳腺恶性孤立性纤维瘤:1例罕见病例报告
Int J Clin Exp Pathol. 2014 Jun 15;7(7):4461-6. eCollection 2014.
10
Malignant solitary fibrous tumor of the thyroid: a case-report and review of the literature.甲状腺恶性孤立性纤维瘤:一例报告并文献复习
Arq Bras Endocrinol Metabol. 2014 Jun;58(4):402-6. doi: 10.1590/0004-2730000003230.

引用本文的文献

1
Metastatic Carcinomas at the Episiotomy Site: A Systematic Literature Review.会阴切开术部位的转移性癌:一项系统文献综述
Cancers (Basel). 2025 Aug 27;17(17):2801. doi: 10.3390/cancers17172801.
2
Lipoleiomyomas of the Uterine Cervix: A New Series including the First Recurrent Case and the First Systematic Literature Review.子宫颈脂肪平滑肌瘤:一个新的病例系列,包括首例复发病例及首次系统性文献综述
J Pers Med. 2022 Nov 6;12(11):1852. doi: 10.3390/jpm12111852.
3
Successful Surgical Treatment of a Recurrent Pelvic Solitary Fibrous Tumor of Uterine Origin Accompanied by Doege-Potter Syndrome: A Case Report.
成功治疗伴 Doege-Potter 综合征的复发性源于子宫的盆腔孤立性纤维瘤:一例报告。
Am J Case Rep. 2022 Oct 13;23:e936806. doi: 10.12659/AJCR.936806.
4
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, , , and Other Genes.关于前列腺癌中PD-L1表达我们需要了解什么?一项系统文献综述(第6部分):PD-L1表达与错配修复系统状态及其他基因的相关性
Biomedicines. 2022 Jan 22;10(2):236. doi: 10.3390/biomedicines10020236.
5
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 7: PD-L1 Expression in Liquid Biopsy.关于前列腺癌中PD-L1表达我们需要了解什么?一项系统文献综述。第7部分:液体活检中的PD-L1表达
J Pers Med. 2021 Dec 6;11(12):1312. doi: 10.3390/jpm11121312.
6
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation Variables.我们需要了解前列腺癌中 PD-L1 表达的哪些方面?系统文献综述。第 1 部分:重点关注免疫组织化学结果,并讨论分析前和解释变量。
Cells. 2021 Nov 14;10(11):3166. doi: 10.3390/cells10113166.
7
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 2: Clinic-Pathologic Correlations.前列腺癌中 PD-L1 表达我们需要了解什么?系统文献回顾。第 2 部分:临床-病理相关性。
Cells. 2021 Nov 14;10(11):3165. doi: 10.3390/cells10113165.
8
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment.我们需要了解前列腺癌中 PD-L1 表达的哪些信息?系统文献回顾。第 3 部分:PD-L1、细胞内信号通路和肿瘤微环境。
Int J Mol Sci. 2021 Nov 15;22(22):12330. doi: 10.3390/ijms222212330.
9
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1.关于前列腺癌中程序性死亡受体配体1(PD-L1)表达我们需要了解什么?一项系统文献综述。第5部分:PD-L1的表观遗传调控
Int J Mol Sci. 2021 Nov 15;22(22):12314. doi: 10.3390/ijms222212314.
10
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models).我们需要了解前列腺癌中 PD-L1 表达的哪些信息?系统文献回顾。第 4 部分:临床前研究中的实验治疗(细胞系和小鼠模型)。
Int J Mol Sci. 2021 Nov 14;22(22):12297. doi: 10.3390/ijms222212297.